Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Библиографические подробности
Главные авторы:	Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
Формат:	Conference item
Опубликовано:	2011

Схожие документы

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
по: Gillies, R, и др.
Опубликовано: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
по: Gillies, R, и др.
Опубликовано: (2012)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
по: Hatch, S, и др.
Опубликовано: (2014)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
по: Graf, Nora, и др.
Опубликовано: (2012)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
по: MacGregor, T, и др.
Опубликовано: (2018)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
по: Hatch, S, и др.
Опубликовано: (2014)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
по: T. P. MacGregor, и др.
Опубликовано: (2018-05-01)

Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy
по: Sharma, R, и др.
Опубликовано: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
по: Gillies, R, и др.
Опубликовано: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
по: Gillies, R, и др.
Опубликовано: (2012)

XPF-ERCC1: Linchpin of DNA crosslink repair
по: McHugh, PJ
Опубликовано: (2020)

XPF-ERCC1: Linchpin of DNA crosslink repair.
по: Peter J McHugh
Опубликовано: (2020-04-01)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
по: Mariangela Sabatella, и др.
Опубликовано: (2021-01-01)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
по: Findlay, J, и др.
Опубликовано: (2017)

Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
по: Yang, J, и др.
Опубликовано: (2010)

Oesophageal and gastro-oesophageal junction tumours
по: Bird-Lieberman, E, и др.
Опубликовано: (2007)

Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
по: Anwaar Ahmad, и др.
Опубликовано: (2010-03-01)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
по: Findlay, J, и др.
Опубликовано: (2017)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
по: den Boer, RB, и др.
Опубликовано: (2020)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
по: Ming-Yii Huang, и др.
Опубликовано: (2023-05-01)

Biochemical studies on the role of the XPF-ERCC1 endonuclease in repairing damaged DNA replication forks
по: Abdullah, U
Опубликовано: (2015)

ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures
по: Shibo Li, и др.
Опубликовано: (2019-06-01)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
по: Millo, J, и др.
Опубликовано: (2003)

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
по: Kaina Bernd, и др.
Опубликовано: (2010-09-01)

Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors
по: Thomas, A, и др.
Опубликовано: (2019)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
по: Sile Li, и др.
Опубликовано: (2022-06-01)

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
по: Bhagwat, N, и др.
Опубликовано: (2009)

Function and Interactions of ERCC1-XPF in DNA Damage Response
по: Maryam Faridounnia, и др.
Опубликовано: (2018-12-01)

Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
по: Jiajia Wang, и др.
Опубликовано: (2020-02-01)

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
по: Wang, A, и др.
Опубликовано: (2011)

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
по: Wang, A, и др.
Опубликовано: (2011)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
по: A. G. M. T. Powell, и др.
Опубликовано: (2020-08-01)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
по: Findlay, J, и др.
Опубликовано: (2016)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
по: Jing Xue, и др.
Опубликовано: (2023-12-01)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
по: Xin Zhang, и др.
Опубликовано: (2021-07-01)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
по: Gillies, R, и др.
Опубликовано: (2011)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
по: Rana, M, и др.
Опубликовано: (2021)

A “Inscrição do Harém” de Xerxes (XPf): introdução crítica, tradução de XPf/OP para o português, comparação com XPf/AB e comentários
по: Matheus Treuk Medeiros de Araújo
Опубликовано: (2024-05-01)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
по: Mukherjee, S, и др.
Опубликовано: (2017)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
по: Gillies, R, и др.
Опубликовано: (2010)